The ACNP Annual Meeting is one of the world’s leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs.
It provides an opportunity to:
• Attend an outstanding scientific program in clinical and basic research on brain behavior-drug interactions.
• Learn about the most recent and often unpublished advances in psychopharmacology.
• Meet and interact with internationally distinguished researchers and scientists.
And of course, we can’t miss it and will be there!
With over 20 years of experience in CNS and Psychiatry, GCT’s expertise can be a valuable asset for Pharma and Biotech companies focused on neurodegenerative diseases.
Meet Jeffrey T. Apter, our President, who oversees all AD and CNS trials at GCT.
Dr. Apter is KOL in psychiatry and has over 30 years of experience in clinical research in psychiatry, focusing on Alzheimer’s disease. Discuss Global Clinical Trials (GCT) experience in CNS, AD and also other indications including recruitment strategies, best performing sites, data collection and latest regulatory changes.
👉 You can request a meeting with Jeffrey T. Apter at bd@gctrials.com